Clinical trial
A Study to Assess the Consequences of Postprandial Lipemia in CRP as Inflammatory Marker in High-risk Adults, to Investigate Whether Hypolipidemic, Hypoglycemic or Antihypertensive Medication May Lessen the Exaggerated Postprandial Lipemia and Evaluate the Influence of Gene Polymorphisms Involved in Lipid and Glucose Metabolism on Postprandial Lipemia and Cardiovascular Outcomes.
NCT02163044 is registered in ClinicalTrials.gov with Hellenic College of Treatment of Atherosclerosis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study to Assess the Consequences of Postprandial Lipemia in CRP as Inflammatory Marker in High-risk Adults, to Investigate Whether Hypolipidemic, Hypoglycemic or Antihypertensive Medication May Lessen the Exaggerated Postprandial Lipemia and Evaluate the Influence of Gene Polymorphisms Involved in Lipid and Glucose Metabolism on Postprandial Lipemia and Cardiovascular Outcomes.
- Lead sponsor
- Hellenic College of Treatment of Atherosclerosis
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2014
- Completion date
- August 31, 2019
- Enrollment
- 580 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
coronary heart disease, dyslipidemia